New Lifesaving Blood Cancer Drug OKd

Thursday, 07 Mar 2013 09:28 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Pomalyst (pomalidomide) has been approved by the FDA to treat cases of multiple myeloma that have not responded to other therapies.

The disease, a form of blood cancer, affects some 21,700 Americans annually and nearly 10,700 die from it each year, the agency said Friday in a news release.

Pomalyst is designed to spur the immune system to destroy and inhibit cancer cells, the FDA said. The drug's safety and effectiveness were evaluated in a clinical study of 221 people with advanced multiple myeloma.

Obamacare
: Massive New Rules Revealed for 2013

The drug's label will contain a boxed warning that it shouldn't be used by pregnant women since it can cause life-threatening birth defects and blood clots, the FDA said.

More common side effects could include a drop in infection-fighting white blood cells, fatigue, weakness, other blood disorders, back pain and fever.

The drug is marketed by Celgene, based in Summit, N.J.

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Two 'Breakthrough' Drugs for Lung Disease

Thursday, 16 Oct 2014 12:40 PM

Roche Holding AG (ROG) and Boehringer Ingelheim GmbH won approval for the first therapies in the U.S. to treat the deadl . . .

Drug Fights Chemo Nausea

Tuesday, 14 Oct 2014 12:24 PM

The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to . . .

Drug-Coated Catheter Clears Blocked Leg Arteries

Tuesday, 14 Oct 2014 12:20 PM

The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been app . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved